Reposar, Jhon Rey B.
HRN: 07-39-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/31/2023
02/09/2023
IV
1g
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes